AU6502194A - Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use - Google Patents

Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use

Info

Publication number
AU6502194A
AU6502194A AU65021/94A AU6502194A AU6502194A AU 6502194 A AU6502194 A AU 6502194A AU 65021/94 A AU65021/94 A AU 65021/94A AU 6502194 A AU6502194 A AU 6502194A AU 6502194 A AU6502194 A AU 6502194A
Authority
AU
Australia
Prior art keywords
oestriol
prophylaxis
humans
preparing
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65021/94A
Inventor
Marika Ehrlich
Claudia Jung-Hoffmann
Herbert Kuhl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6502194A publication Critical patent/AU6502194A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AU65021/94A 1993-06-08 1994-04-14 Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use Abandoned AU6502194A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4319096 1993-06-08
DE19934319096 DE4319096C1 (en) 1993-06-08 1993-06-08 Hormonal composition for the prevention and treatment of arterial disorders in man
PCT/DE1994/000418 WO1994028905A1 (en) 1993-06-08 1994-04-14 Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use

Publications (1)

Publication Number Publication Date
AU6502194A true AU6502194A (en) 1995-01-03

Family

ID=6489950

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65021/94A Abandoned AU6502194A (en) 1993-06-08 1994-04-14 Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use

Country Status (3)

Country Link
AU (1) AU6502194A (en)
DE (2) DE4319096C1 (en)
WO (1) WO1994028905A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4442766C2 (en) * 1993-06-08 1996-11-07 Kuhl Herbert Prof Dr Phil Nat Hormonal agent for the prevention and treatment of arterial diseases in men
US5877169A (en) * 1993-11-05 1999-03-02 University Of Florida Research Foundation, Inc. Methods of treatment of ischemic damage
US6339078B1 (en) 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
US6326365B1 (en) 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
US7674783B2 (en) * 2002-11-22 2010-03-09 Dimera Inc. Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1261348A (en) * 1968-04-02 1972-01-26 Leo Ab Treatment of hair and scalp and compositions therefor
DE2364373A1 (en) * 1973-12-22 1975-07-10 Hahn Carl Dr Gmbh Pharmaceutical and/or cosmetic prepns. - contg. methyl-substd. xanthine, oestriol and/or a mucopolysaccharide
SU712090A1 (en) * 1976-11-22 1980-01-30 Минский Ордена Трудового Красного Знамени Государственный Медицинский Институт Agent suppressing the contraction activity of uterus
US4210644A (en) * 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US4863911A (en) * 1986-08-04 1989-09-05 University Of Florida Method for treating male sexual dysfunction
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
DE3933460A1 (en) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts OSTROGEN-ACTIVE PLASTER
JP3295735B2 (en) * 1991-04-19 2002-06-24 久光製薬株式会社 Estriol transdermal patch
DE9312236U1 (en) * 1993-07-22 1993-10-14 Umbreit Klaus Dr Med Medicinal composition for slowing down the aging process in men

Also Published As

Publication number Publication date
DE4493859D2 (en) 1996-09-26
WO1994028905A1 (en) 1994-12-22
DE4319096C1 (en) 1994-09-08

Similar Documents

Publication Publication Date Title
AU4470397A (en) Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions
EP0717592A4 (en) Method and composition for the treatment of apathy-amotivation syndrome
AUPM672594A0 (en) A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
AU6872498A (en) Method and composition for skin treatment
AU5424598A (en) Ozone treatment system for point of use purification of water andsanitizing agent for surfaces, articles and foods
AU2219795A (en) Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
EP0685219A3 (en) Hair treatment agent and process for its use.
AU7227394A (en) Method for surface treatment, means for carrying out the method and the use thereof
EP0674834A3 (en) Pretzel and method for preparation of the same.
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
AU1438295A (en) Method for treatment of papulo-pustules and comedones of the skin
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AUPM771894A0 (en) Method for the treatment of indirect inguinal hernias and related conditions
AU2825295A (en) Method for the treatment, prevention or minimization of hair loss
IL116142A0 (en) Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
EP0681787A3 (en) Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis.
AU5718994A (en) Method for the treatment of incineration residues and the use thereof as adsorption agent
AU6502194A (en) Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use
EP0618233A3 (en) Process for the preparation and treatment of N-hydroxyalkylchitosane soluble in aqueous medium.
AU2843397A (en) Agent for prophylaxis and treatment of disturbance of visual function
AU2068295A (en) Skin treatment composition
AU3061199A (en) Skin treatment compositions and the use thereof